Glendale Memorial's Cancer Services participates in many National Cancer Institute (NCI) cooperative group trials and cutting edge pharmaceutical and biotech sponsored studies. Our cancer patients can benefit from getting involved in a cancer research trial by being the first to test the latest possible cancer treatment breakthroughs.
Clinical research trials offer physicians and patients the opportunity to participate in advancing medical science by helping establish new and innovative treatments.
Glendale Memorial's Cancer Services is currently involved in the following research trials:
- Bladder/Prostate Cancer
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- SELECT (prostate)
- STAR Trial (breast)
For information on our current research trials, please call the Glendale Memorial Cancer Research Office at (818) 409-7653.
Institutional Review Board
An Institutional Review Board is a committee charged with protecting the rights and welfare of people participating in research activities. The board reviews and approves research applications involving human subjects, provides ongoing oversight to ensure regulatory compliance, and assures that the risks to research subjects are minimized and participation by these subjects is done so on a voluntary, informed basis.
Both the Food and Drug Administration and the Office for Human Research Protections set the guidelines and regulations governing human subjects research and establish the authority granted to the Institutional Review Board, encouraging all investigators, coordinators, sponsors and research volunteers to contact them for questions, advice or concerns at any time. Any questions, concerns or suggestions will be responded to in a confidential and professional manner.
The National Institutes of Health provide a glossary of terms; health and human services provides a IRB Guidebook.